Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
08 Nov 2021
Placement and Underwritten Entitlement Offer to Raise $12.4m
04 Nov 2021
Amplia and CRUK agree to Amend Licence Terms - AMP886
04 Nov 2021
Trading Halt
27 Oct 2021
Quarterly Activities and Cashflow Reports - Sep 2021 Qtr
26 Oct 2021
Amplia Appoints New Oncology Clinical Advisor
19 Oct 2021
Amplia Provides Updated Investor Presentation
14 Oct 2021
Amplia Receives $1.1m R&D Tax Incentive
01 Oct 2021
Amplia Appoints New Chief Financial Officer
30 Sep 2021
New Garvan Publication Supports Amplia Phase 2 Design
28 Sep 2021
Proactive Investors Lifesciences Webinar Presentation
Previous
1
2
3
4
5
6
7
8
9
Next
